Study of a Flu Vaccine in Children

National Institute of Allergy and Infectious Diseases (NIAID)15,000 enrolled

Overview

This study tests the safety and effectiveness of a flu vaccine in school children. School children are usually the first members of a community to come down with the flu, and they often give the flu to their younger siblings, parents, and grandparents. It is hoped that giving school children a flu vaccine can help prevent the spread of the flu to other members of the community.

This is a Phase III trial (an advanced study with a large number of patients). Your child will receive a single dose of flu vaccine, which is given by a nasal spray.

Study Type

INTERVENTIONAL

Purpose

PREVENTION

Masking

NONE

Enrollment

15,000

Conditions

Influenza

Interventions

Influenza virus vaccine (CAIV-T)BIOLOGICAL

Eligibility

Sex: ALLMin age: 18 MonthsMax age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Your child may be eligible for this study if he/she: * Is between the ages of 18 months and 18 years, with consent of parent or guardian. * Is a resident of the Temple-Belton, Texas area. Exclusion Criteria: Your child will not be eligible for this study if he/she: * Has had a fever within 3 days before vaccination. * Has symptoms of a weakened immune system. * Has had a wheezing episode within the past 2 weeks. * Has moderate to severe asthma. * Is allergic to eggs. * Needs to take aspirin on a regular basis. * Has received another vaccine or study drug in the past month.

Locations (1)

Pedro A. Piedra, M.D.

Houston, Texas, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.